Furthermore, inhibition of USP25 by AZ1 in a mouse model was shown to suppress inflammation linked to bacterial infections in the intestine and enhance the immune response while inhibiting the activity of USP25 in promoting intestinal cancer (Wang et al, 2020). This evidence concerns the gene USP25 and bacterial infectious disease.